Consistent with its possible function as a tumour suppressor gene, PPARγ has been reported to be functionally mutated in sporadic cases of colon cancer (Sarraf et al, 1999); nonetheless, the overall incidence of PPARγ mutations in human malignancies seems to be very rare (Ikezoe et al, 2001). This evidence concerns the gene PPARG and malignant colon neoplasm.